Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | FABP6 | P51161 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.37 |
| ▸ | NPC1 | O15118 | 7/20 | 0.37 |
| ▸ | RAB9A | P51151 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.37 |
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL271074 | 0.82 | FABP6 (0.43) | CYP3A4FABP6ALDH1A1NPC1RAB9A | |
| Water SCHEMBL2493413 | 0.80 | FABP6 (0.42) | CYP3A4FABP6ALDH1A1NPC1RAB9A | |
| Water SCHEMBL29778699 | 0.80 | FABP6 (0.42) | CYP3A4FABP6ALDH1A1NPC1RAB9A | |
| SCHEMBL21314047 | 0.79 | BCHE (0.32) | FABP6 | |
| Water SCHEMBL11187894 | 0.78 | FABP6 (0.41) | CYP3A4FABP6ALDH1A1NPC1RAB9A | |
| SCHEMBL31716781 | 0.78 | AMY1A (0.33) | FABP6ALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL12180644 | 0.78 | MAPT (0.35) | ALDH1A1KDM4EMAPTHSD17B10TDP1 | |
| Water SCHEMBL11194637 | 0.77 | FABP6 (0.39) | CYP3A4FABP6ALDH1A1NPC1RAB9A | |
| SCHEMBL12121753 | 0.75 | DAO (0.36) | FABP6 | |
| SCHEMBL1021150 | 0.75 | GRIN2D (0.44) | CYP3A4FABP6ALDH1A1GAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160060222-A1 | AMINO-QUINOLINES AS KINASE INHIBITORS | GLAXOSMITHKLINE LLC | 2016-03-03 | — | — | US | disclosed |
| EP-2566477-B1 | AMINO-QUINOLINES AS KINASE INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2015-09-02 | — | — | EP | disclosed |
| EP-2121858-B1 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | ARKEMA INC (US) | 2013-10-16 | — | — | EP | disclosed |
| US-8450402-B2 | Method for reducing plate out of aqueous coating compositions | ARKEMA INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-8450401-B2 | Aqueous coating composition having reduced plate out | ARKEMA INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-20130053375-A1 | AMINO-QUINOLINES AS KINASE INHIBITORS | GLAXO GROUP LIMITED | 2013-02-28 | — | — | US | disclosed |
| WO-2011140442-A1 | AMINO-QUINOLINES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2011-11-10 | — | — | WO | disclosed |
| EP-2121824-B8 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | ARKEMA INC (US) | 2011-02-23 | — | — | EP | disclosed |
| EP-2121824-B1 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | ARKEMA INC (US) | 2011-01-12 | — | — | EP | disclosed |
| US-20100324169-A1 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | DOW GLOBAL TECHNOLOGIES, INC (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100319579-A1 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | ARKEMA INC. | 2010-12-23 | — | — | US | disclosed |
| EP-2121858-A2 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-25 | — | — | EP | disclosed |
| EP-2121824-A2 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008100608-A2 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | DOW GLOBAL TECHNOLOGIES, INC (US) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008100607-A2 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | DOW GLOBAL TECHNOLOGIES, INC (US) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060222-A1 | AMINO-QUINOLINES AS KINASE INHIBITORS | ABL1, MAP3K2, MAP4K2 | TERT 2767/4885CYP3A4 3225/4885TSHR 2105/4885 |
| US-20130053375-A1 | AMINO-QUINOLINES AS KINASE INHIBITORS | ABL1, MAP3K2, MAP4K2 | TERT 2767/4885CYP3A4 3225/4885TSHR 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.